(Q28248896)

27 March 2017

author name string

Mihir M Thacker

series ordinal

1

1 reference

27 March 2017

H Thomas Temple

series ordinal

2

1 reference

27 March 2017

Sean P Scully

series ordinal

3

1 reference

27 March 2017

language of work or name

English

0 references

publication date

April 2005

1 reference

Expert Review of Anticancer Therapy

27 March 2017

published in

1 reference

27 March 2017

volume

5

1 reference

27 March 2017

issue

2

1 reference

27 March 2017

page(s)

319-31

0 references

319-331

1 reference

Treatment of Ewing sarcoma family of tumors: current status and outlook for the future

27 March 2017

cites work

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.2.319

Influence of Doxorubicin Dose Intensity on Response and Outcome for Patients With Osteogenic Sarcoma and Ewing's Sarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.2.319

Addition of ifosfamide and etoposide to standard chemotherapy for Ewing's sarcoma and primitive neuroectodermal tumor of bone

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.2.319

Ifosfamide and etoposide plus vincristine, doxorubicin, and cyclophosphamide for newly diagnosed Ewing's sarcoma family of tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.2.319

Pharmacological management of Ewing sarcoma family of tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.2.319

Hematologic abnormalities and acute myeloid leukemia in children and adolescents administered intensified chemotherapy for the Ewing sarcoma family of tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.2.319

Local therapy in localized Ewing tumors: results of 1058 patients treated in the CESS 81, CESS 86, and EICESS 92 trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.2.319

Ewing sarcoma: radiation dose and target volume

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.2.319

Local control and function after twice-a-day radiotherapy for Ewing's sarcoma of bone

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.2.319

Definitive irradiation in multidisciplinary management of localized Ewing sarcoma family of tumors in pediatric patients: outcome and prognostic factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.2.319

Local control and functional results after twice-daily radiotherapy for Ewing's sarcoma of the extremities

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.2.319

Postoperative radiotherapy in the treatment of Ewing tumors: influence of the interval between surgery and radiotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.2.319

Role of radiotherapy in Ewing tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.2.319

Primary metastatic (stage IV) Ewing tumor: survival analysis of 171 patients from the EICESS studies. European Intergroup Cooperative Ewing Sarcoma Studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.2.319

Allogeneic and autologous stem-cell transplantation in advanced Ewing tumors. An update after long-term follow-up from two centers of the European Intergroup study EICESS. Stem-Cell Transplant Programs at Düsseldorf University Medical Center, German

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.2.319

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.2.319

Rotationplasty--surgical treatment modality after failed limb salvage procedure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.2.319

High cervical disc herniation and Brown-Sequard syndrome. A case report and review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.2.319

The versatility of the free osteocutaneous fibula flap in the reconstruction of extremities after sarcoma resection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.2.319

Free fibula long bone reconstruction in orthopedic oncology: a surgical algorithm for reconstructive options.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.2.319

Clavicula pro humero--a new surgical method for malignant tumors of the proximal humerus

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.2.319

Growing endoprostheses for primary malignant bone tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.2.319

Early Multicenter Experience With a Noninvasive Expandable Prosthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.2.319

Ewing's sarcoma of bone. Experience with 140 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.2.319

Local and systemic control in Ewing's sarcoma of the femur treated with chemotherapy, and locally by radiotherapy and/or surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.2.319

Ewing's sarcoma of the pelvis: combined surgery and radiotherapy treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.2.319

Treatment options in primary Ewing's sarcoma of the spine: report of seven cases and review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.2.319

Long-term outcome for patients with non-metastatic Ewing's sarcoma treated with adjuvant and neoadjuvant chemotherapies. 402 patients treated at Rizzoli between 1972 and 1992.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.2.319

A systematic review of molecular and biological markers in tumours of the Ewing's sarcoma family.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.2.319

Irinotecan for pediatric solid tumors: the Memorial Sloan-Kettering experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.2.319

Phase I trial of temozolomide and protracted irinotecan in pediatric patients with refractory solid tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.2.319

Taking aim at Ewing's sarcoma: is KIT a target and will imatinib work?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.2.319

c-KIT-expressing Ewing tumour cells are insensitive to imatinib mesylate (STI571).

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.2.319

C-kit receptor expression in Ewing's sarcoma: lack of prognostic value but therapeutic targeting opportunities in appropriate conditions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.2.319

High-dose busulphan/melphalan with autologous stem cell rescue in Ewing's sarcoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.2.319

High-dose therapy for patients with primary multifocal and early relapsed Ewing's tumors: results of two consecutive regimens assessing the role of total-body irradiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.2.319

Increased risk of systemic relapses associated with bone marrow micrometastasis and circulating tumor cells in localized ewing tumor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.2.319

High-dose therapy with autologous stem cell rescue for pediatric sarcomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.2.319

Megatherapy and stem cell transplantation for Ewing's family of tumors: a critical review of current literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.2.319

Variability in gene expression patterns of Ewing tumor cell lines differing in EWS-FLI1 fusion type

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.2.319

EWS-Fli1 antisense oligodeoxynucleotide inhibits proliferation of human Ewing's sarcoma and primitive neuroectodermal tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.2.319

EWS fli-1 antisense nanocapsules inhibits ewing sarcoma-related tumor in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.2.319

Tumoricidal activity of tumor necrosis factor-related apoptosis-inducing ligand in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.2.319

The rapamycin-sensitive signal transduction pathway as a target for cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.2.319

Rapamycin induces the fusion-type independent downregulation of the EWS/FLI-1 proteins and inhibits Ewing's sarcoma cell proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.2.319

Sensitization for death receptor- or drug-induced apoptosis by re-expression of caspase-8 through demethylation or gene transfer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.2.319

Functional and molecular characterization of interleukin-2 transgenic Ewing tumor cells for in vivo immunotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.2.319

Pilot trial of tumor-specific peptide vaccination and continuous infusion interleukin-2 in patients with recurrent Ewing sarcoma and alveolar rhabdomyosarcoma: an inter-institute NIH study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.2.319

EWS/FLI-1 silencing and gene profiling of Ewing cells reveal downstream oncogenic pathways and a crucial role for repression of insulin-like growth factor binding protein 3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.2.319

Human brain-cell death induced by tumour-necrosis-factor-related apoptosis-inducing ligand (TRAIL)

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.2.319

Long-Term Follow-Up and Prognostic Factors in Ewing’s Sarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.2.319

21 January 2018

Identifiers

DOI

10.1586/14737140.5.2.319

1 reference